Patents by Inventor Nicolas FORAY

Nicolas FORAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10197578
    Abstract: A method for predicting cellular, tissular, and clinical radiosensitivity, based on the determination and correlation of several cellular and enzymatic parameters.
    Type: Grant
    Filed: February 16, 2015
    Date of Patent: February 5, 2019
    Assignees: UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CENTRE LEON BERARD, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Nicolas Foray, Adeline Granzotto, Clément Devic
  • Patent number: 10180437
    Abstract: A method for predicting cellular, tissue and clinical radiosensitivity, which is based on the determination and correlation of multiple parameters and cellular and enzymatic criteria.
    Type: Grant
    Filed: February 16, 2015
    Date of Patent: January 15, 2019
    Assignees: UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CENTRE LEON BERARD, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Nicolas Foray, Adeline Granzotto, Clément Devic
  • Publication number: 20180238860
    Abstract: A predictive method of cell toxicity after exposure to chemical elements breaking DNA directly or indirectly (particularly certain metals, pesticides and certain active substances for chemotherapy) and which is based on the determination and cross-checking of a plurality of cellular and enzymatic parameters and criteria.
    Type: Application
    Filed: August 16, 2016
    Publication date: August 23, 2018
    Inventors: Nicolas FORAY, Mélanie FERLAZZO, Lauréne SONZOGNI, Larry BODGI, Sandrine PEREIRA
  • Publication number: 20180238859
    Abstract: A predictive method of cellular, tissue and clinical radiosensitivity, which is based on the determination and cross-checking of a plurality of cellular and enzymatic parameters and criteria applied to a tumor response. The predictive method characterizes the sensitivity of a tumor in response to a DNA-breaking radiotherapy treatment.
    Type: Application
    Filed: August 16, 2016
    Publication date: August 23, 2018
    Applicants: NEOLYS DIAGNOSTICS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, CENTRE LEON BERARD, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE CLAUDE BERNARD LYON 1
    Inventors: Nicolas FORAY, Larry BODGI, Sandrine PEREIRA
  • Publication number: 20170010254
    Abstract: A method for predicting cellular, tissue and clinical radiosensitivity, which is based on the determination and correlation of multiple parameters and cellular and enzymatic criteria.
    Type: Application
    Filed: February 16, 2015
    Publication date: January 12, 2017
    Inventors: Nicolas FORAY, Adeline GRANZOTTO, Clément DEVIC
  • Publication number: 20170010279
    Abstract: A method for predicting cellular, tissular, and clinical radiosensitivity, based on the determination and correlation of several cellular and enzymatic parameters.
    Type: Application
    Filed: February 16, 2015
    Publication date: January 12, 2017
    Inventors: Nicolas FORAY, Adeline GRANZOTTO, Clément DEVIC